SBIR/STTR Research Award
Unified high performance analysis of imaging biomarkers for Alzheimer's disease
Award amount
$1,800,000Program and phase
SBIR · Phase IIAward year
2014Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- PIERSON BRAIN IMAGE ANALYSIS
- Proposal award date
- 2014-08-01
- Contract end date
- 2017-06-30
- UEI
- Not reported
- Solicitation number
- PA11-134
- Topic code
- NIA
Research abstract
DESCRIPTION provided by applicant Alzheimerandapos s disease is a neurodegenerative disease of the brain causing impairments to memory and cognitive functions eventually leading to death The causes of Alzheimerandapos s disease and mechanisms of disease progression are not fully understood but an enormous amount of effort is being focused on the issues in research and pharmacologic interventions Brain Image Analysis LLC has developed NeuroAnalytica to provide high quality brain morphometry measures for biomarkers in Alzheimerandapos s disease This Phase II project will expand the basic measures to include a wide range of modalities and measures that research has shown to be useful in as potential biomarkers in Alzheimerandapos s disease PUBLIC HEALTH RELEVANCE Alzheimerandapos s disease is a neurodegenerative disease of the brain causing impairments to memory and cognitive functions eventually leading to death The causes of Alzheimerandapos s disease and mechanisms of disease progression are not fully understood but an enormous amount of effort is being focused on the issues in research and pharmacologic interventions Brain Image Analysis LLC has developed NeuroAnalytica to provide high quality brain morphometry measures for biomarkers in Alzheimerandapos s disease This Phase II project will expand the basic measures to include a wide range of modalities and measures that research has shown to be useful in as potential biomarkers in Alzheimerandapos s disease
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Evaluate the Safety, Tolerability, and Immunogenicity of Adjuvanted Preventive Dual Aβ/tau Vaccine, Duvax in Healthy Volunteers
- A Drug Discovery Platform to Prioritize Development of Natural Product Neuromodulators for Treating Cognitive Impairment
- VR-CARES: Feasibility of Virtual Reality for Caregiver Assembly, Relief, Empowerment, and Support to improve social connection, health, and at-home dementia care
- Developing an Integrated Brain State Monitor for Personalized Anesthesia Decision Support: Preventing Postoperative Delirium in Elderly and Patients At Risk for Alzheimer's or Related Dementias
- Lead Optimization of a Therapeutic Candidate for Alzheimer’s Disease